Boston Scientific CorporationBSXNYSE
Loading
Debt to Equity Over TimeFair Value
Percentile Rank21
3Y CAGR-1.0%
5Y CAGR-3.8%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-1.0%/yr
vs -10.0%/yr prior
5Y CAGR
-3.8%/yr
Consistent
Acceleration
+9.0pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.51 | +0.1% |
| 2024 | 0.51 | +4.0% |
| 2023 | 0.49 | -6.8% |
| 2022 | 0.53 | -7.1% |
| 2021 | 0.57 | -8.6% |
| 2020 | 0.62 | -16.0% |
| 2019 | 0.74 | -8.1% |
| 2018 | 0.81 | +1.3% |
| 2017 | 0.80 | -2.3% |
| 2016 | 0.81 | - |